Loading...
menu
Search
AI Trading Bot
Features
Markets
News
Resources
Pricing
Get Started
Home
Stock
SYRE
SYRE News & Events
-
Add to Watchlist
Trade SYRE Autonomously
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
Overview
Stock Price Prediction
Technical
Valuation
Financials
Earnings
Should I Buy
News & Events
SYRE News
Spyre Therapeutics Grants Stock Options to Employees
5d ago
Newsfilter
Biotech Sector Approaches Critical Phase 2 Milestones
May 28 2026
Newsfilter
HighVista Strategies Cuts Stake in Viridian Therapeutics by $7 Million
May 17 2026
Yahoo Finance
Spyre Therapeutics Q1 Earnings Miss Expectations Amid $403M Stock Offering
May 05 2026
seekingalpha
Spyre Therapeutics (SYRE.US) Officer Plans to Sell $5.83 Million in Common Stock via Form 144
May 01 2026
moomoo
Spyre Therapeutics Grants Stock Options to Employees
May 01 2026
Newsfilter
Spyre Therapeutics Prices Public Offering at $62 per Share
Apr 15 2026
NASDAQ.COM
Spyre Therapeutics Upsizes Public Offering to Raise $403 Million
Apr 15 2026
seekingalpha
Show More News
SYRE Events
06/03 08:20
Spyre Therapeutics Completes Enrollment for All Sub-Studies in SKYWAY Trial of SPY072
Spyre Therapeutics announced the completion of enrollment for all sub-studies in the SKYWAY basket trial of SPY072 in rheumatic diseases.
Show More Events
SYRE Monitor News
Spyre Therapeutics grants stock options to employees
Jun 09 2026
Spyre Therapeutics stock rises after crossing above SMA
Apr 29 2026
Spyre Therapeutics CEO sells shares amid clinical trial advancements
Apr 13 2026
SYRE Earnings Analysis
No Data
People Also Watch
